Pitfalls and Success in Surgical Treatment of Focal Epilepsy*

W. Penfield
DOI: https://doi.org/10.1136/bmj.1.5072.669
1958-03-22
British Medical Journal
Abstract:with troxidone. This does not necessitate withdrawal of the drug but requires added caution and more frequent blood-cell counts. The appearance of signs of kidney dysfunction requires immediate withdrawal of the drug. Paramethadione (" Paradione").-Paramethadione is a close analogue of troxidone. Its dosage schedule and toxicity are similar. Toxic manifestations are less frequent, and intolerance to troxidone does not necessarily mean intolerance to paramethadione. Its use is indicated in those patients with petit-mal seizures who are refractory to treatment or develop toxic reactions to troxidone. Occasionally the combination of both drugs gives better results than either one alone. The same precautions that were detailed for troxidone apply to the use of paramethadione. Phensuximide (" Milontin ").-This is indicated for the treatment of petit mal when troxidone and paramethadione, administered either alone or in combination, have proved ineffective. The starting dose is 0.5 g. three times a day, with gradual increases of 0.5 g. Therapeutic effect is usually obtained in the range of 2 to 3 g. a day. The limiting sideeffects are nausea, vomiting, dizziness, drowsiness, and dreamlike states. These disappear with adjustment of dosage or withdrawal of the drug. Transient microscopic haematuria has been reported during its administration, but all investigations are not in agreement regarding occurrence or significance. It would seem wise to do urinalyses and blood-cell counts at stated intervals for patients receiving the drug for long periods until more is known about its toxic manifestations.
What problem does this paper attempt to address?